Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT

MeSH terms

• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / therapeutic use
• Base Sequence
• Benzamides / adverse effects*
• Benzamides / therapeutic use
• Female
• Genetic Variation
• Heterozygote
• Humans
• Hyperpigmentation / chemically induced*
• Imatinib Mesylate
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
• Middle Aged
• Mutation
• Palate, Hard / pathology*
• Piperazines / adverse effects*
• Piperazines / therapeutic use
• Proto-Oncogene Mas
• Proto-Oncogene Proteins c-kit / genetics
• Pyrimidines / adverse effects*
• Pyrimidines / therapeutic use